1. A therapeutic agent for corneal endothelial dysfunction, containing (R) - (+) - N- (1H-pyrrolo [2,3-b] pyridin-4-yl) -4- (1-aminoethyl) benzamide or a pharmacologically acceptable salt as an active ingredienta.2. The therapeutic agent according to claim 1, which is an eye kapli.3. The agent for promoting adhesion of corneal enedotelialnyh cells containing (R) - (+) - N- (1H-pyrrolo [2,3-b] pyridin-4-yl) -4- (1-aminoethyl) benzamide or a pharmacologically acceptable salt thereof .4. The medium for culturing corneal endothelial cell, comprising at p.3.5 agent. Implant for corneal endothelial keratoplasty soderzhaschiya) corneal endothelial cells, and c) the frame uc) (R) - (+) - N- (1H-pyrrolo [2,3-b] pyridin-4-yl) -4- (1- aminoethyl) benzamide or a pharmacologically acceptable sol.6. The implant of claim 5 wherein produced corneal endothelial cells lyudey.7. A process for preparing corneal endothelial preparation, comprising a step of culturing corneal endothelial cells using the culture medium containing (R) - (+) - N- (1H-pyrrolo [2,3-b] pyridin-4-yl) -4- ( 1-aminoethyl) benzamide or a pharmacologically acceptable sol.8. Method of preparation according to claim 7, wherein lyudey.9 prepared corneal endothelial cells. A method for treating corneal endothelial dysfunction, comprising the step of producing a corneal endothelial preparation and / or corneal implant for endothelial keratoplasty, each of which contains (R) - (+) - N- (1H-pyrrolo [2,3-b] pyridin-4- yl) -4- (1-aminoethyl) benzamide or a pharmacologically acceptable salt thereof, and a step of corneal endothelial preparation transplantation and / or an implant for corneal endothelial kerato1. Терапевтический агент против корнеальной эндотелиальной дисфункции, содержащий (R)-(+)-N-(1H-пирроло[2,3-b]пиридин-4-ил)-4-(1-аминоэтил)бензамид или его фармакологически приемлемую соль в качестве активного ингредиента.2. Терапевтический агент по п.1, который представляет собой глазные капли.3. Агент для стимулирован